ACE2 and prognosis of COVID-19: Insights from Bartter's and Gitelman's syndromes patients.

Calò, Lorenzo A; Davis, Paul A; Rigato, Matteo; Sgarabotto, Luca

Calò, Lorenzo A; Davis, Paul A; Rigato, Matteo; Sgarabotto, Luca.

Calò LA; Department of Medicine, Nephrology, Dialysis and Transplantation Unit, University of Padova, Italy.
Davis PA; Department of Nutrition, University of California, Davis, California.
Rigato M; Department of Medicine, Nephrology, Dialysis and Transplantation Unit, University of Padova, Italy.
Sgarabotto L; Department of Medicine, Nephrology, Dialysis and Transplantation Unit, University of Padova, Italy.

J Med Virol ; 92(11): 2308-2309, 2020 11.

Article in English | MEDLINE | ID: covidwho-186736

Subject(s)

Angiotensin-Converting Enzyme 2; COVID-19; Humans; Pandemics; Peptidyl-Dipeptidase A; Prognosis; SARS-CoV-2

Keywords

ACE2; Bartter's syndrome; COVID-19; Gitelman's syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Angiotensin-Converting Enzyme 2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Med Virol Year: 2020 Document Type: Article Affiliation country: Jmv.25978

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google